Scientists are unraveling the role of senescent cells in a common form of epilepsy, and it could point to new treatments.

Epileptic activity originating from one or more diseased brain regions in the temporal lobe is difficult to contain. Many patients with so-called temporal lobe epilepsy often do not respond to ...

In a retrospective cohort, a clinical heuristic composed of eight binary variables helped identify which patients with medial temporal lobe epilepsy (MTLE) were best suited for stereotactic laser ...

Mesial temporal lobe epilepsy, which accounts for about 80% of all temporal lobe seizures, involves seizures starting in or near a part of the brain called the hippocampus, which controls memory and ...

Please provide your email address to receive an email when new articles are posted on . Retrospective chart review included 29 patients with drug-resistant epilepsy who underwent LITT. Better 1-year ...

(RTTNews) - Elekta AB Ser. B (EKTA-B.ST) announced that the U.S. Food and Drug Administration has granted 510(k) clearance for its Leksell Gamma Knife radiosurgery system to treat refractory, ...

In what could lead to a revolutionary advancement in the treatment of temporal lobe epilepsy, UC San Diego Health has become one of the first health systems in the country to inject regenerative cells ...

Researchers studying epileptic seizures of the temporal lobe -- the most common type of epilepsy -- discovered a compound that reduces seizures in the hippocampus, a brain region where many such ...